Robert Z. Orlowski (@myeloma_doc) 's Twitter Profile
Robert Z. Orlowski

@myeloma_doc

Deputy Chair of Lymphoma/Myeloma, Vice Chair MM Research @ MD Anderson; Translational researcher who hates myeloma. Tweets are my own. Retweets ≠ endorsements.

ID: 187354183

linkhttps://orcid.org/0000-0002-5723-4129 calendar_today06-09-2010 00:32:59

41,41K Tweet

15,15K Followers

4,4K Following

Robert Z. Orlowski (@myeloma_doc) 's Twitter Profile Photo

#Myeloma Paper of the Day: Patients w/ >8.7 mos between last exposure to prior BCMA-directed therapy & teclistamab have significantly improved median PFS w/ tec (8.1 mos, 95% CI: 4.6-11.7) vs. pts with <8.7 mos (2.5 ms, 95% CI: 1.1-5.7), p=0.001: pubmed.ncbi.nlm.nih.gov/40562770/. #mmsm

#Myeloma Paper of the Day: Patients w/ &gt;8.7 mos between last exposure to prior BCMA-directed therapy &amp; teclistamab have significantly improved median PFS w/ tec (8.1 mos, 95% CI: 4.6-11.7) vs. pts  with &lt;8.7 mos (2.5 ms, 95% CI: 1.1-5.7), p=0.001: pubmed.ncbi.nlm.nih.gov/40562770/. #mmsm